Evaluation of Screening Results for Vancomycin-Resistant Enterococci: Three-Year Surveillance
,
Abstract
-
1. Sohn KM, Peck KR, Joo EJ, et al (2013). Duration of colonization and risk fac-tors for prolonged carriage of vanco-mycin-resistant enterococci after dis-charge from the hospital. Int J Infect Dis, 17(4):e240-6.
2. Uttley AH, Collins CH, Naidoo J, et al (1988). Vancomycin resistant enterococ-ci. Lancet, 1(8575-6):57-8.
3. Vehreschild MJGT, Haverkamp M, Biehl LM, et al (2019). Vancomycin-resistant enterococci (VRE): a reason to isolate? Infection, 47(1):7-11.
4. Şardan YÇ. (2003). The experience of van-comycin-resistant enterococci in Turkey: The Case of Hacettepe. ANKEM Derg, 17(3):151-2.
5. Patel R (2003). Clinical impact of vanco-mycin-resistant enterococci. J Antimicrob Chemother, 51 Suppl 3:iii13-21.
6. Woodford N, Johnson AP, Morrison D, et al (1995). Current perspectives on glyco-peptide resistance. Clin Microbiol Rev, 8(4):585-615.
7. Mundy LM, Sahm DF, Gilmore M (2000). Relationships between enterococcal vir-ulence and antimicrobial resistance. Clin Microbiol Rev, 13(4):513-22.
8. Hendrix CW, Hammond JM, Swoboda SM, et al (2001). Surveilance strategies and impact of vancomycinresistant entero-coccal colonization and infection in critically ill patients. Ann Surg, 233(2):259-65.
9. Zhou W, Sun HZY, Gao S, et al (2020). Characterization of clinical enterococci isolates, focusing on the vancomycinre-sistant enterococci in a tertiary hospital in China: based on the data from 2013 to 2018. BMC Infect Dis, 20:356.
10. Avcıoğlu F, Altınöz Aytar A, Öztürk E, et al (2016). Evaluation of vancomycin-resistant enterococcal colonization in Düzce University Research and Practice Hospital. Duzce Medical Journal, 18(1):8-11.
11. Bulut A, Şengül H, Kaşıkçı ÖH (2018). Van-comycin-Resistant Enterococcus Surveil-lance Study: A State Hospital Example. Journal of Academic Research in Nursing (JAREN), 2018;4(1):21-27.
12. Kirişçi Ö, Çalışkan A (2020). Evaluation of Vancomycin-Resistant Enterococci Growing in Clinical Samples with Rectal Screening Specimens: A Seven-Year Sur-veillance, A Retrospective Cross-sectional Study. ANKEM Derg, 34(3):105-11.
13. Alçi G, Güneşer D, Güner A, Karahasan A (2021). Screening for Vancomycin-Resistant Enterococci in Rectal Swab Samples from Hospitalized Patients: Strategic Evaluation. ANKEM Derg, 35(3):70-76.
14. Çetinkaya Y (2000). Vancomycin-Resistant Enterococci: Epidemiology and Con-trol. Flora Derg, 5(1):24-33.
15. Tacconelli E, Cataldo MA (2008). Vanco-mycin-resistant enterococci (VRE): Transmission and control. Int J Antimi-crob Agents, 31:99-106.
16. Byers KE, Anglimm AM, Anneski CJ, Farr BM (2002). Duration of colonization with vancomycin-resistant enterococcus. Infect Control Hosp Epidemiol, 23:207-11.
17. Warren DK, Kollef H, Seiler S, et al (2003). The epidemiology of Vancomycin-Resistant Enterococcus colonization in the medical intensive-care unit. Infect Control Hosp Epidemiol, 24:257-63.
18. Güdücüoğlu H, Aktaş E, Cömert FB, et al (2009). [First isolation and detection of multiple clones of vancomycin-resistant enterococci in the pediatric unit of Van Yuzuncu Yil University Turkey]. Mikrobiyol Bul, 43(4):535-43.
19. Kutlu M, Kutlu SS, Şardan YÇ, et al (2006). Investigation of nosocomial vancomy-cin resistant enterococcal colonization. Journal of Hospital Infections, 10(3):173-7.
20. No authors listed (1995). Recommenda-tions for preventing the spread of van-comycin resistance. Recommendations of the Hospital Infection Control Prac-tices Advisory Committee (HICPAC). MMWR Recomm Rep, 44(RR-12):1-13.
21. De Lisle S, Perl TM (2003). Vancomycin-Resistant Enterococci: A road map on how to prevent the emergence and transmission of antimicrobial resistance. Chest, 123(5 Suppl):504S-18S.
22. Korten V (2013). Multidrug resistant gram positive bacteria (MRSA and VRE): Treatment and Control. ANKEM Derg, 27(2):57-62.
23. Yiş R, Aslan S, Çıtak Ç, Değirmenci S (2011). Evaluation of vancomycin-resistant enterococcal colonization in Gaziantep pediatric hospital. Mikrobiyol Bul, 45(4):646-54.
24. Yiş R (2018). Comparison of Culture Results with BD GeneOhm VanR Test Results in Screening for Vancomycin-Resistant Enterococci. Türk Mikrobiyol Cem Derg, 48(1):45-51.
25. Kılıç FK, Çalkavur S, Olukman Ö, et al (2012). Vancomycin-resistant enterococ-cal colonization management in the ne-onatal intensive care unit: Lessons from an epidemic. Journal of Dr. Behcet Uz Chil-dren’s Hospital, 2(3):148-153.
26. Song JY, Cheong HJ, Jo YM, et al (2009). Vancomycin Resistant Enterococcus colo-nization before admission to the inten-sive care unit: Aclinico-epidemiologic analysis. Am J Infect Control, 37(9):734-40.
27. Jung E, Byun S, Lee H, et al (2014). Vanco-mycin resistant Enterococcus colonization in the intensive care unit: Clinical out-comes and attributable costs of hospital-ization. Am J Infect Control, 42(10):1062-66.
2. Uttley AH, Collins CH, Naidoo J, et al (1988). Vancomycin resistant enterococ-ci. Lancet, 1(8575-6):57-8.
3. Vehreschild MJGT, Haverkamp M, Biehl LM, et al (2019). Vancomycin-resistant enterococci (VRE): a reason to isolate? Infection, 47(1):7-11.
4. Şardan YÇ. (2003). The experience of van-comycin-resistant enterococci in Turkey: The Case of Hacettepe. ANKEM Derg, 17(3):151-2.
5. Patel R (2003). Clinical impact of vanco-mycin-resistant enterococci. J Antimicrob Chemother, 51 Suppl 3:iii13-21.
6. Woodford N, Johnson AP, Morrison D, et al (1995). Current perspectives on glyco-peptide resistance. Clin Microbiol Rev, 8(4):585-615.
7. Mundy LM, Sahm DF, Gilmore M (2000). Relationships between enterococcal vir-ulence and antimicrobial resistance. Clin Microbiol Rev, 13(4):513-22.
8. Hendrix CW, Hammond JM, Swoboda SM, et al (2001). Surveilance strategies and impact of vancomycinresistant entero-coccal colonization and infection in critically ill patients. Ann Surg, 233(2):259-65.
9. Zhou W, Sun HZY, Gao S, et al (2020). Characterization of clinical enterococci isolates, focusing on the vancomycinre-sistant enterococci in a tertiary hospital in China: based on the data from 2013 to 2018. BMC Infect Dis, 20:356.
10. Avcıoğlu F, Altınöz Aytar A, Öztürk E, et al (2016). Evaluation of vancomycin-resistant enterococcal colonization in Düzce University Research and Practice Hospital. Duzce Medical Journal, 18(1):8-11.
11. Bulut A, Şengül H, Kaşıkçı ÖH (2018). Van-comycin-Resistant Enterococcus Surveil-lance Study: A State Hospital Example. Journal of Academic Research in Nursing (JAREN), 2018;4(1):21-27.
12. Kirişçi Ö, Çalışkan A (2020). Evaluation of Vancomycin-Resistant Enterococci Growing in Clinical Samples with Rectal Screening Specimens: A Seven-Year Sur-veillance, A Retrospective Cross-sectional Study. ANKEM Derg, 34(3):105-11.
13. Alçi G, Güneşer D, Güner A, Karahasan A (2021). Screening for Vancomycin-Resistant Enterococci in Rectal Swab Samples from Hospitalized Patients: Strategic Evaluation. ANKEM Derg, 35(3):70-76.
14. Çetinkaya Y (2000). Vancomycin-Resistant Enterococci: Epidemiology and Con-trol. Flora Derg, 5(1):24-33.
15. Tacconelli E, Cataldo MA (2008). Vanco-mycin-resistant enterococci (VRE): Transmission and control. Int J Antimi-crob Agents, 31:99-106.
16. Byers KE, Anglimm AM, Anneski CJ, Farr BM (2002). Duration of colonization with vancomycin-resistant enterococcus. Infect Control Hosp Epidemiol, 23:207-11.
17. Warren DK, Kollef H, Seiler S, et al (2003). The epidemiology of Vancomycin-Resistant Enterococcus colonization in the medical intensive-care unit. Infect Control Hosp Epidemiol, 24:257-63.
18. Güdücüoğlu H, Aktaş E, Cömert FB, et al (2009). [First isolation and detection of multiple clones of vancomycin-resistant enterococci in the pediatric unit of Van Yuzuncu Yil University Turkey]. Mikrobiyol Bul, 43(4):535-43.
19. Kutlu M, Kutlu SS, Şardan YÇ, et al (2006). Investigation of nosocomial vancomy-cin resistant enterococcal colonization. Journal of Hospital Infections, 10(3):173-7.
20. No authors listed (1995). Recommenda-tions for preventing the spread of van-comycin resistance. Recommendations of the Hospital Infection Control Prac-tices Advisory Committee (HICPAC). MMWR Recomm Rep, 44(RR-12):1-13.
21. De Lisle S, Perl TM (2003). Vancomycin-Resistant Enterococci: A road map on how to prevent the emergence and transmission of antimicrobial resistance. Chest, 123(5 Suppl):504S-18S.
22. Korten V (2013). Multidrug resistant gram positive bacteria (MRSA and VRE): Treatment and Control. ANKEM Derg, 27(2):57-62.
23. Yiş R, Aslan S, Çıtak Ç, Değirmenci S (2011). Evaluation of vancomycin-resistant enterococcal colonization in Gaziantep pediatric hospital. Mikrobiyol Bul, 45(4):646-54.
24. Yiş R (2018). Comparison of Culture Results with BD GeneOhm VanR Test Results in Screening for Vancomycin-Resistant Enterococci. Türk Mikrobiyol Cem Derg, 48(1):45-51.
25. Kılıç FK, Çalkavur S, Olukman Ö, et al (2012). Vancomycin-resistant enterococ-cal colonization management in the ne-onatal intensive care unit: Lessons from an epidemic. Journal of Dr. Behcet Uz Chil-dren’s Hospital, 2(3):148-153.
26. Song JY, Cheong HJ, Jo YM, et al (2009). Vancomycin Resistant Enterococcus colo-nization before admission to the inten-sive care unit: Aclinico-epidemiologic analysis. Am J Infect Control, 37(9):734-40.
27. Jung E, Byun S, Lee H, et al (2014). Vanco-mycin resistant Enterococcus colonization in the intensive care unit: Clinical out-comes and attributable costs of hospital-ization. Am J Infect Control, 42(10):1062-66.
| Files | ||
| Issue | Vol 53 No 8 (2024) | |
| Section | Original Article(s) | |
| DOI | https://doi.org/10.18502/ijph.v53i8.16279 | |
| Keywords | ||
| Vancomycin-resistant enterococci Vancomycin-resistant enterococci (VRE) Rectal swab Real-time PCR | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
How to Cite
1.
Ayaydın Z, Azarkan AB, Alkan Bilik Özge, Tekin AC. Evaluation of Screening Results for Vancomycin-Resistant Enterococci: Three-Year Surveillance. Iran J Public Health. 2024;53(8):1746-1753.
